Medical Education
Top 5 Cannabis Strains: July 2017
The article you're reading is a rewritten version of a 2017 list of cannabis strains, originally published by archive. While the original content was a personal preference list, this version focuses on the medical and...
The article you're reading is a rewritten version of a 2017 list of cannabis strains, originally published by archive. While the original content was a personal preference list, this version focuses on the medical and safety considerations for patients and carers using cannabis. It provides a factual overview of the strains mentioned, their characteristics, and the importance of understanding how cannabis can be used safely and effectively in a medical context.
Key takeaways
- The original list includes five cannabis strains: Holy Grail Kush, Shoreline, Chemdawg, Blue Dream, and Hawaiian Haze.
- These strains are described based on their aroma, taste, and effects, but this information is subjective and not based on clinical evidence.
- The potency and method of use (e.g., smoking, vaping) can significantly affect the experience and safety of cannabis use.
- Patients should not rely on personal preference lists when making medical decisions; they should consult with a healthcare professional to determine the most appropriate strain and method of use for their condition.
Evidence base
The original source material is a personal opinion piece, not a clinical or scientific review. It does not provide evidence-based information on the efficacy or safety of the listed strains for medical use. While some cannabis strains may have anecdotal benefits for certain conditions, such as chronic pain or anxiety, these effects are not universally consistent and can vary widely between individuals. The potency of cannabis strains is often measured in terms of tetrahydrocannabinol (THC) and cannabidiol (CBD) content, but these levels can vary significantly between batches and strains.
There is limited evidence to support specific strains being more effective for particular conditions. The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) do not recommend specific cannabis strains for medical use due to the lack of robust clinical trials. The method of use—such as smoking, vaping, or oral ingestion—can also influence the onset, duration, and intensity of effects. Smoking and vaping may pose additional health risks, including respiratory issues, and are not recommended for long-term use.
Patients should be aware that the route of administration can affect how cannabis is absorbed and how it interacts with the body.
What patients should know
Cannabis can be used for a variety of medical conditions, including chronic pain, nausea, and anxiety, but its use should be carefully managed. It is important to understand that the effects of cannabis can vary significantly between individuals, and what works for one person may not work for another. Patients should not assume that a strain listed in a personal preference list will be effective or safe for their specific needs.
The potency of cannabis strains can influence the intensity of effects, and higher THC content may increase the risk of adverse effects such as anxiety, paranoia, or impaired cognitive function. Patients should be cautious about the potency of the product they are using and consider starting with a lower dose to assess how their body reacts. It is also important to be aware of the legal status of cannabis in the UK, as it remains a controlled substance, and its use is subject to specific regulations.
Patients should be aware that cannabis use can interact with other medications, and it is important to discuss all current medications with a healthcare professional before starting cannabis. The long-term effects of cannabis use are not fully understood, and there is evidence that regular use may affect mental health, particularly in individuals with a history of psychiatric conditions. Patients should be encouraged to monitor their symptoms and report any changes to their clinician.
When to speak to a clinician
Patients should consult with a healthcare professional before starting cannabis for medical use, especially if they have a history of mental health issues, are taking other medications, or have a chronic condition. It is important to discuss the potential benefits and risks of cannabis use and to determine the most appropriate strain and method of administration. Red flags that may indicate the need for immediate medical attention include severe anxiety, paranoia, hallucinations, or difficulty breathing. Patients should also seek medical advice if they experience persistent side effects or if their symptoms worsen after starting cannabis. Regular follow-up appointments are recommended to monitor the effectiveness of cannabis and to adjust the treatment plan as needed.
Questions to ask a clinician
- What are the potential benefits and risks of using cannabis for my specific condition?
- How can I determine the appropriate strain and potency for my needs?
- Are there any interactions between cannabis and the medications I am currently taking?
Source trail
- archive Top 5 Cannabis Strains July 2017 (original source material) - UK Medicines and Healthcare products Regulatory Agency (MHRA) guidance on cannabis use - National Institute for Health and Care Excellence (NICE) guidelines on cannabis for medical use